Serum anti-Müllerian hormone levels: a novel measure of ovarian reserve.
By I.A.J. van Rooij, Frank J. Broekmans, E. R. Velde, Bart C. J. M. Fauser, L. Bancsi, F. Jong, A. Themmen. Human Reproduction, 2002
1,017 citations recorded by the source corpus.
Subfields: Endocrinology, Diabetes and Metabolism, Reproductive Medicine
View Paper: https://www.semanticscholar.org/paper/e9d3f2fc11c0b049bfba7ca84b8a278272fbf80c
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Endocrinology, Diabetes and Metabolism
In Reproductive Medicine
Citations in the corpus
- Anti-Müllerian hormone expression pattern in the human ovary: potential implications for initial and cyclic follicle recruitment. (2004, background): “Serum levels of AMH in regularly cycling women decrease over time and there is a strong correlation between AMH and the number of antral follicles (de Vet et al., 2002; van Rooij et al., 2002 ).”
- Anti-Mullerian hormone (AMH) as a predictive marker in assisted reproductive technology (ART). (2010, neutral): “Van Rooij et al. (2002) 130 0.”
- Anti-Müllerian hormone: ovarian reserve testing and its potential clinical implications. (2014, positive): “A similar association between AMH and age, AFC, and FSH was subsequently described in women undergoing IVF (van Rooij et al., 2002).”